the Waluj plant could be hurt by roughly 9 per cent of estimated FY’14 sales, they estimated. The impact on overall profits could be higher than 10 per cent, they said since there could be other costs relating to remediation.
*The implications of the import alert on consolidated revenues expected to be in the range of $100 million
*Earlier this month, the UK regulator barred the company from producing drugs for Europe from the same plant
*The US is Wockhardt’s biggest market and fetched the company $531 million in revenues in FY’13
*he warning could hit sales from the Waluj plant by 9%